Applied DNA Sciences (APDN) Reports In-Line Q4 EPS, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
NET LOSS FROM OPERATIONS: -2.41M
Today's EPS Names:
SICP, OMID, ELME, More
Financial Fact:
NET LOSS FROM OPERATIONS: -2.41M
Today's EPS Names:
SICP, OMID, ELME, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.67 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 1st Source (SRCE) PT Raised to $92 at KBW After a 'High Quality Result'
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Verizon Communications (VZ) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
Corporate News, Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
